Impact of pharmacist collaborative practice agreement on pharmacogenomic implementation for patients referred from geriatric medicine

Key Points

• The implementation of a collaborative practice agreement leads to enhanced pharmacogenomic testing outcomes.
• A positive impact was observed in the pharmacist-led service for geriatric patients receiving pharmacogenomic care.
• This study utilized an observational analysis approach to evaluate outcomes of pharmacogenomic testing services.
• The findings support the integration of collaborative practice agreements in improving patient-centered care for geriatric populations.